Low bleeding rates following transbronchial lung cryobiopsy in unclassifiable interstitial lung disease
- PMID: 38355891
- DOI: 10.1111/resp.14678
Low bleeding rates following transbronchial lung cryobiopsy in unclassifiable interstitial lung disease
Abstract
Background and objective: Bronchoscopic transbronchial lung cryobiopsy (TBLC) is a guideline-endorsed alternative to surgical lung biopsy for tissue diagnosis in unclassifiable interstitial lung disease (ILD). The reported incidence of post-procedural bleeding has varied widely. We aimed to characterize the incidence, severity and risk factors for clinically significant bleeding following TBLC using an expert-consensus airway bleeding scale, in addition to other complications and diagnostic yield.
Methods: A retrospective cohort study of consecutive adult outpatients with unclassifiable ILD who underwent TBLC following multidisciplinary discussion at a single centre in the UK between July 2016 and December 2021. TBLC was performed under general anaesthesia with fluoroscopic guidance and a prophylactic endobronchial balloon.
Results: One hundred twenty-six patients underwent TBLC (68.3% male; mean age 62.7 years; FVC 86.2%; DLCO 54.5%). Significant bleeding requiring balloon blocker reinflation for >20 min, admission to ICU, packed red blood cell transfusion, bronchial artery embolization, resuscitation or procedural abandonment, occurred in 10 cases (7.9%). Significant bleeding was associated with traction bronchiectasis on HRCT (OR 7.1, CI 1.1-59.1, p = 0.042), a TBLC histological pattern of UIP (OR 4.0, CI 1.1-14, p = 0.046) and the presence of medium-large vessels on histology (OR 37.3, CI 6.5-212, p < 0.001). BMI ≥30 (p = 0.017) and traction bronchiectasis on HRCT (p = 0.025) were significant multivariate predictors of longer total bleeding time (p = 0.017). Pneumothorax occurred in nine cases (7.1%) and the 30-day mortality was 0%. Diagnostic yield was 80.6%.
Conclusion: TBLC has an acceptable safety profile in experienced hands. Radiological traction bronchiectasis and obesity increase the risk of significant bleeding following TBLC.
Keywords: interstitial lung disease; interventional bronchoscopy; interventional pulmonology; risk factors; transbronchial lung biopsy.
© 2024 Asian Pacific Society of Respirology.
Similar articles
-
Implementation of transbronchial lung cryobiopsy in a tertiary referral center for interstitial lung diseases: a cohort study on diagnostic yield, complications, and learning curves.BMC Pulm Med. 2021 Feb 25;21(1):67. doi: 10.1186/s12890-021-01438-1. BMC Pulm Med. 2021. PMID: 33632180 Free PMC article.
-
Transbronchial lung cryobiopsy for diagnosing interstitial lung disease: a cross-sectional, comparative study.Eur J Med Res. 2025 Mar 14;30(1):171. doi: 10.1186/s40001-025-02435-4. Eur J Med Res. 2025. PMID: 40087668 Free PMC article.
-
A systematic review of procedural and sampling techniques for cryobiopsy in interstitial lung disease.Eur Respir Rev. 2024 Aug 14;33(173):240035. doi: 10.1183/16000617.0035-2024. Print 2024 Jul. Eur Respir Rev. 2024. PMID: 39142710 Free PMC article.
-
Transbronchial lung cryobiopsy for interstitial lung disease: early experience, learning curve, and the impact of sedation on complication rates at a single centre in Japan.BMC Pulm Med. 2024 Oct 29;24(1):540. doi: 10.1186/s12890-024-03359-1. BMC Pulm Med. 2024. PMID: 39472830 Free PMC article.
-
Diagnostic yield and safety of transbronchial lung cryobiopsy and surgical lung biopsy in interstitial lung diseases: a systematic review and meta-analysis.Eur Respir Rev. 2022 Oct 5;31(166):210280. doi: 10.1183/16000617.0280-2021. Print 2022 Dec 31. Eur Respir Rev. 2022. PMID: 36198419 Free PMC article.
Cited by
-
An insight into interventional bronchoscopy.Clin Med (Lond). 2025 May;25(3):100321. doi: 10.1016/j.clinme.2025.100321. Epub 2025 May 5. Clin Med (Lond). 2025. PMID: 40334941 Free PMC article. Review.
-
A nomogram model integrating radiomics and clinical variables to predict napsin a expression in lung adenocarcinoma patients.Front Oncol. 2025 Jul 4;15:1595406. doi: 10.3389/fonc.2025.1595406. eCollection 2025. Front Oncol. 2025. PMID: 40687424 Free PMC article.
References
REFERENCES
-
- Colby TV, Tomassetti S, Cavazza A, Dubini A, Poletti V. Transbronchial cryobiopsy in diffuse lung disease: update for the pathologist. Arch Pathol Lab Med. 2017;141(7):891–900.
-
- Troy LK, Grainge C, Corte TJ, Williamson JP, Vallely MP, Cooper WA, et al. Diagnostic accuracy of transbronchial lung cryobiopsy for interstitial lung disease diagnosis (COLDICE): a prospective, comparative study. Lancet Respir Med. 2020;8(2):171–181.
-
- Ravaglia C, Bonifazi M, Wells AU, Tomassetti S, Gurioli C, Piciucchi S, et al. Safety and diagnostic yield of transbronchial lung cryobiopsy in diffuse parenchymal lung diseases: a comparative study versus video‐assisted thoracoscopic lung biopsy and a systematic review of the literature. Respiration. 2016;91(3):215–227.
-
- Tomassetti S, Wells AU, Costabel U, Cavazza A, Colby TV, Rossi G, et al. Bronchoscopic lung cryobiopsy increases diagnostic confidence in the multidisciplinary diagnosis of idiopathic pulmonary fibrosis. Am J Respir Crit Care Med. 2016;193(7):745–752.
-
- Raghu G, Remy‐Jardin M, Richeldi L, Thomson CC, Inoue Y, Johkoh T, et al. Idiopathic pulmonary fibrosis (an update) and progressive pulmonary fibrosis in adults: an official ATS/ERS/JRS/ALAT clinical practice guideline. Am J Respir Crit Care Med. 2022;205(9):e18–e47.
MeSH terms
LinkOut - more resources
Full Text Sources
Medical